3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
3
Venous Thrombosis
2
Neoplasms
2
Urinary Tract Infections
1
Thrombosis
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Embolism
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Interventions
Dalteparin
9
apixaban
6
Heparin, Low-Molecular-Weight
3
Enoxaparin
3
edoxaban
2
abelacimab
2
Tinzaparin
2
Rivaroxaban
2
MAA868
2
Dabigatran
2
isoquercitrin
1
enoxaparin sodium
1
bemiparin
1
Warfarin
1
Rosuvastatin Calcium
1
Fondaparinux
1
Educational Status
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pulmonary Embolism
×
Warfarin
×
Classical hematology
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts